A Novel Fusicoccin Derivative Preferentially Targets Hypoxic Tumor Cells and Inhibits Tumor Growth in Xenografts

E-ISSN： 1875-5992|12|7|791-800

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.12, Iss.7, 2012-09, pp. : 791-800

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice

By Allegrini Giacomo Goulette Frederick Darnowski James Calabresi Paul

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 3, 2004-03 ,pp. : 261-266

Springer Publishing Company

Access to resources Recommend Favorite

Metronomic treatment of malignant glioma xenografts with irinotecan (CPT-11) inhibits angiogenesis and tumor growth

By Takano Shingo Kamiyama Hiroshi Mashiko Ryota Osuka Satoru Ishikawa Eiichi Matsumura Akira

Journal of Neuro-Oncology, Vol. 99, Iss. 2, 2010-09 ,pp. : 177-185

Springer Publishing Company

Access to resources Recommend Favorite

Capecitabine combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts

Experimental and Therapeutic Medicine, Vol. 3, Iss. 4, 2012-01 ,pp. : 650-654

Spandidos Publications

Access to resources Recommend Favorite

Salinomycin inhibits the growth of colorectal carcinoma by targeting tumor stem cells

Oncology Reports, Vol. 34, Iss. 5, 2015-01 ,pp. : 2469-2476

Spandidos Publications

Access to resources Recommend Favorite

Identification of novel therapeutic targets in the secretome of ionizing radiationinduced senescent tumor cells

Oncology Reports, Vol. 35, Iss. 2, 2016-01 ,pp. : 841-850

Spandidos Publications

Access to resources Recommend Favorite